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Background: TALEs (transcription activator-like effectors) are powerful molecules that have broad applications in
genetic and epigenetic manipulations. The simple design of TALEs, coupled with high binding predictability and
specificity, is bringing genome engineering power to the standard molecular laboratory. Currently, however, custom
TALE assembly is either costly or limited to few research centers, due to complicated assembly protocols, long
set-up time and specific training requirements.
Results: We streamlined a Golden Gate-based method for custom TALE assembly. First, by providing ready-made,
quality-controlled monomers, we eliminated the procedures for error-prone and time-consuming set-up. Second,
we optimized the protocol toward a fast, two-day assembly of custom TALEs, based on four thermocycling
reactions. Third, we increased the versatility for diverse downstream applications by providing series of vector sets
to generate both TALENs (TALE nucleases) and TALE-TFs (TALE-transcription factors) under the control of different
promoters. Finally, we validated our system by assembling a number of TALENs and TALE-TFs with DNA
sequencing confirmation. We further demonstrated that an assembled TALE-TF was able to transactivate a luciferase
reporter gene and a TALEN pair was able to cut its target.
Conclusions: We established and validated a do-it-yourself system that enables individual researchers to assemble
TALENs and TALE-TFs within 2 days. The simplified TALE assembly combined with multiple choices of vectors will
facilitate the broad use of TALE technology.
Keywords: TALEN, TALE-TF, Golden Gate, Transcription-activator-like effectorBackground
With the recent emergence of transcription activator-like
effector (TALE) technology, gene editing has entered an
exciting new era [1-3]. While zinc finger nucleases have
been well established for the purpose of generating tar-
geted mutations [4], their challenging design and need for
experimental optimization have restricted this technology
to few, highly specialized laboratories. In contrast, TALEs
are simple to design, able to target almost any DNA se-
quence within the genome, and promise less off-target
effects compared to zinc-finger nucleases [5-7].
Native TALEs are transcription factors used by plant-
pathogenic bacteria in the genus Xanthomonas. They acti-
vate transcription of host genes by binding to specific
sequences in the promoter region of the targeted gene
[8,9]. Strikingly, the TALE DNA binding domain consists* Correspondence: BLu@systembio.com
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distribution, and reproduction in any mediumof tandem 33–35 amino acid repeats, followed by a single
half repeat of 20 amino acids. Interestingly, the tandem
repeats are nearly identical, except for two amino acid
codons at position 12 and 13, referred to as “repeat-
variable di-residue” (RVD). Each of the four most common
RVDs specifies the binding to one of the four nucleotide
bases [10,11]. Taking advantage of the simplicity of the
TALE coding principle, customized TALEs can be easily
designed to allow genetic and epigenetic manipulation. For
example, the TALE DNA-binding domains can be com-
bined with either a catalytic DNA endonuclease domain,
such as FokI, to allow gene editing, or a transcription factor
(TF) domain for gene activation. Indeed, both TALEN and
TALE-TF, have been successfully applied to gene-editing or
activation in a number of species [2,12-16].
Because of the repetitive nature of the DNA binding do-
main, the assembly of customized TALEs by direct synthe-
sis or traditional cloning is expensive and technically
challenging. Realizing the potential of TALE technology, antral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,

























































Figure 1 Schematic overview of multimer assembly from the ready-made monomer library into a vector of choice for gene editing or
gene activation.
1. Choosing monomers 
2. Multimer assembly 
3. Exonuclease treatment
4. Multimer amplification
5. Electrophoresis and 
gel purification of multimers 




5 min     5 min
3 h 30 min
1.2 h 10 min
1.3 h 30 min
Day II
2 h 1 h
Time
total       bench
Time
total       bench
1.5 h 30 min
4.5 h 30 min
Figure 2 Workflow of TALEN and TALE-TF assembly, using the
do-it-yourself TALE assembly kit. The total time and the actual
hands-on time of the 7 assembly steps are indicated on the right.
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devised to allow low to medium throughput ([5,17]), or
high-throughput with automation [18,19]. It is worthy to
note that these methods are based on the Golden Gate
procedure, a cloning strategy that makes use of type IIs re-
striction enzymes which cut sequences adjacent, rather
than within their recognition sites, and allows seamless
ligation of repetitive sequences in a specific order [5,17].
The Golden Gate cloning technique has proven powerful,
but typically relies on the use of large numbers of plasmids
or amplified monomers, making this strategy not feasible
for the individual research lab.
The objective of this research was to establish a system
for simple TALE assembly, and to develop vector sets
with gene editing or gene activation capability under the
control of different promoters, to allow for a variety of
downstream applications.
Results and discussion
We established a do-it-yourself system for the fast and
simple assembly of TAL-repeats into a collection of vec-
tors for TALEN and TALE-TF expression in mammalian
cells (Figure 1). This system simplifies the assembly of
custom TALEs in three main ways. First, by eliminating
the need for time-consuming and error-prone set-up, it
shortens time, effort and cost of assembly. Second, by
providing a streamlined protocol, it simplifies an other-
wise complicated approach, making it feasible for any
standard molecular lab. And lastly, a collection of back-
bone vectors with TALEN and TALE-TF domains under
the control of various promoters offers choices for
diverse downstream applications in the mammaliansystem. Using this approach, individual researchers can
assemble one or several TALEs into a vector of choice in
just 2 days (Figure 2) by using standard molecular tech-
niques and a thermocyler.
The assembly is based on the Golden Gate method,
which relies on the ability of type IIS restriction enzymes
to cut outside of their recognition site. Type IIS recogni-
tion sites arranged in inverse orientation at the 5' and 3'
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allowing simultaneous restriction and ligation. The con-
tinuous re-digestion of unwanted ligation products
increases the formation of the desired construct. As type
IIS fusion sites can be designed to have different
sequences, Golden Gate cloning enables directional and
seamless assembly of multiple DNA fragments.
As a first step of our do-it-yourself protocol, we
assembled monomers into multimers (Figure 3A, B), using
a procedure based on restriction, ligation and amplifica-
tion. Multimer 1 and 2 are designed to be hexamers, but
the length of multimer 3 can vary to allow variations in
the final length, such as 14–19 bp binding sequences. To
remove the incompletely assembled and thus linear
ligation products, DNA exonuclease treatment was carried
out after the multimer assembly. The correctly assembled
circular multimers were subsequently amplified by PCR.
On day 2, gel-purified multimers were assembled into a
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Figure 3 A) A ready-made library of normalized, quality-controlled m
According to the custom TALE design, monomers are assembled into 2–3
thermocycler. In the example shown here, multimer 1 and 2 are hexamers
assembly product in a vector of choice typically results in tens to hundreds
to no colonies D) Correct assembly of multimers into the vector can be as
the TALE binding specificity is based on 4 types of RVDs, color-coding the
tandem repeats. G) For functional validation, a custom TALE domain was a
construct was generated carrying 3 copies of the TALE binding sequence.
construct into HEK293 cells showed strong induction of luciferase activity, cprocedure, followed by bacterial transformation (Figure 3C).
Colony PCR was performed for confirmation of insert
size (Figure 3D); typically, 40-90% of colonies displayed
correct insert size. We recommend to use two colonies of
correct insert size for sequence confirmation (Figure 3E,
F); typically 80-90% of sequences revealed correct assem-
bly. A detailed protocol of this approach is provided in the
Materials and Methods section.
We have successfully assembled a number of custom
TALEs into various vectors. To examine functionality of
an assembled TALE, we performed a co-transfection ex-
periment in human embryonic kidney 293 cells. Consist-
ent with previous findings [20], the custom-assembled
TALE-TF activated luciferase activity 65-fold, validating
its functionality (Figure 3G, H).
To confirm functionality of an assembled TALEN, we
performed a transfection experiment in human embry-
onic kidney 293 cells using a pair of assembled TALENs
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onomers provides the building blocks for TALE assembly. B)
multimers in a restriction and ligation-based procedure, using a
while multimer 3 is a tetramer. C) E. coli transformation with the final
of colonies, while the negative control should have significantly lower
sessed by colony PCR, and further confirmed by sequencing (E). F) As
RVD-encoding nucleotides can quickly reveal the correct order of
ssembled into the EF1-TALE-TF vector. In addition, a dual reporter
H) Co-transfection of the custom TALE-TF and the dual reporter
onfirming the TALE-TF functionality.
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mutation detection assay provides a functional validation
of successful de novo cutting with a particular pair of
TALENs. As shown in Figure 4B, we designed primers
that have an amplicon of 650 bp and flanking the cen-
trally localized TALEN target. PCR-amplifcation using
this primer pair produced a single band in both mock-
and TALEN-transfected samples. After denaturing, het-
eroduplex reannealing and Surveyor nuclease treatment,
AAVS1 TALEN-transfected cells displayed an extra band
of ~320 bp as predicted (Figure 4C-D). These data valid-
ate the function of assembled TALENs using Surveyor
nuclease mutation detection assay.
Conclusions
We established and validated a do-it-yourself strategy
that enables researchers to assemble TALE-TF/TALENs
in just 2 days. The simplicity of this approach and its
minimal hands-on time makes gene-editing an afford-
able and practical choice for the standard molecular
lab. The choices of a number of useful vector setsNLS FoKIN-ter C-terCMV
A
Repeats Effector














Figure 4 TALEN activity in HEK293 cells. A) This schematic shows the g
of a CMV promoter. B) The nucleotide sequences of target sites are 5-TGCC
(bottom stand) flanking a 16-bp spacer. The primers for genomic PCR are 5
3’ (P2). C) Schematic of the Surveyor nuclease mutation detection assay us
the Surveyor nuclease mutation detection result from the assembled AAVS
showed no cutting with Surveyor nucleases, whereas cells transfected with




Free online tools such as TALEN Targeter [6] and
idTALE [21] are available to design TALENs and TALE-
TFs that are specific and have a low risk of off-target
effects. TALE-TFs only require one effector protein, while
TALENs require the design of protein pairs, which bind
two DNA sites, usually spaced 15–30 bp apart to allow for
optimal FokI dimerization and cutting [5]. Length of DNA
binding sequences may vary, typically ranging from 14–20
bp. In humans, 20 bp may offer high specificity, consider-
ing the genome size. It is worthy to note that longer
domains (18–20 bp) may decrease cell toxicity by reducing
the risk of off-target effects [19].
The appropriate vector can be chosen from a collec-
tion of TALEN and TALE-TF backbone vectors, listed in
Table 1, according to the desired downstream applica-
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    C1         C1 24 hr    24 hr    48 hr     48 hr
2.3% 3.4%
eneral configuration of TALENs that were assembled under the control
CCTCCACCCCCAC-3’ (top strand), and 5’-TTTCTGTCACCAATCCTG-3’
’-CTTGCTTTCTTTGCCTGGAC-3’ (P1) and 5’-GATCAGTGAAACGCACCAGA-
ed to determine TALEN de novo cleavage. D) 2% agarose gel showing
1 TALEN pair. Controls (C1) from mock-transfected HEK293 cells
the AAVS1 TALEN pair produced expected ~320 bp products. The
ectively.
Table 1 Available TALE backbone vectors
Vector1 name Promoter Application


























1 All vectors come as a set of four, with RVDs NI (A), NG (T), HD (C) or NN (G)
specifying the nucleotide binding of the terminal half repeat. 2Note that the
half-repeat RVD in the EF1-TALE-TF-NG vector is encoded by AAT GGC instead
of AAC GGA, and that of the TALE-TF-NN vector is encoded by AAT AAC
instead of AACAAC.
Table 2 Components for multimer assembly




BsmBI restriction enzyme 0.75
T7 Ligase 0.25
total 4
Table 3 Thermocycle conditions for multimer assembly
Cycle Number Temperature 1 Temperature 2
1 37°C, 5 min
2-16 20°C, 5 min 37°C, 5 min
Hold at 4°C
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T, G, or C-specific half repeat.
Materials
Reagents
EZ-TAL™ assembly kit (System Biosciences, Mountain
View, CA), includes monomer library, Combo Buffer I,
Combo Buffer II, BsmBI restriction enzyme , BSaI re-
striction enzyme, T7 Ligase, Exo buffer, Exonuclease,
High-fidelity PCR buffer, High-fidelity DNA polymerase,
BSA, DTT, ATP, dNTP, Multimer primer mix, Colony-
PCR primer mix, Sequencing primer SF-1 (forward-1),
Sequencing primer SF-2 (forward-2), and Sequencing
primer SR (reverse).
Additional Reagents not provided in EZ-TAL™ base kit
EZ-TAL™ end monomers for target size 14–19 (Sys-
tem Biosciences)Taq polymerase (New England BioLabs, Ipswich,
MA, #MO267X)
Ultra-Pure Agarose (Life Technologies, Grand Island,
NY, #15510-027)
Agarose Gel Loading Dye Blue (6x) (New England Bio-
Labs, #B70215)
Quick-Load 2-log DNA Ladder (New England Bio
Labs, #N04695)
1X TAE Electrophoresis Buffer (40 mM Tris, 20 mM
acetic acid, and 1 mM EDTA).
Ethidium Bromide (Amresco, Solon, OH, #X328)
QIAquick Extraction Kit (Qiagen, Valencia, CA, #28706)
Chemically Competent Escherichia coli, such as One
Shot Stbl3 chemically competent E. coli (Life Technolo-
gies # C7373-03)
SOC medium (Life Technologies, #46-0700)
LB-Carbenicillin Plates (Teknova, Hollister, CA, #LI008)
LB Broth, (Teknova, #L8000)
Carbenicillin (Teknova, #C2130)Equipment
Thermocycler (PTC-2000 Peltier Thermal Cycler, MJ
Research)
Microfuge tubes (Eppendorf, Hauppauge, NY, 022363204)
Flat-cap PCR tubes (Bio-Rad, Hercules, CA, #TFI0201)
Micropipetters and tips (Rainin, Columbus, OH)
Gel electrophoresis equipment for agarose gels (Bio-Rad)
Gel documentation system (ChemiDOC, Bio-Rad)
Incubator for Heat Shock Treatment (Thermomixer R,
Eppendorf )
37°C Shaker Model G25 Incubator/Shaker, New
Brunswick Scientific)
Culture test tubes with cap (17x100 mm), (Fisherbrand,
Houston, TX, #14-956-6B)
Table 4 Components for exonuclease treatment





Table 6 Components for multimer amplification
Component Amount per 1 reaction (μL)
PCR buffer 10
DNA-grade Water 35.5
Multimer primer mix 2.5
dNTP 0.5
High-fidelity DNA polymerase 0.5
total 49








HoDivide the target sequences of 14-20 nucleotides into
multimers, excluding the first (5’) T and the last (3’)
nucleotide, which is vector encoded. The first two
multimers should be hexamers, the last multimer is
variable in size and contains however many monomers
remain (excluding the vector-encoded last nucleotide).
Example T | A T C G C C | T C T A G C | C A C
T* | G
Take the corresponding color-coded monomers from
the EZ-TAL™ kit (Figure 1). A special set of “end”
monomers can be used to adjust for target sizes
shorter than 20 nucleotides (14-19).
2. Multimer assembly (bench time 30 min, total time 3
hours).
In a separate tube for each multimer, pipette 1 μL of
each monomer; adjust last multimer to 6 μL with
H2O if necessary.
Example
Multimer 1: A1 + T2 + C3 + G4 + C5 + C6
Multimer 2: T7 + C8 + T9 + A10 + G11 + C12
Multimer 3: C13 + A14 + C15 + T16end + 2 μL H2O
Combine components specified in Table 2. Add 4 μL
of mix to each multimer for a total of 10 μL. Place
each multimer tube in a thermocycler and use
cycling conditions specified in Table 3 for ~ 2.5
hours.
3. Exonuclease treatment (bench time 10 min, total
time 1.2 hours)
To degrade any noncircular ligation products, add
components specified in Table 4.ble 5 Thermocycle conditions for exonuclease
eatment
cle Number Temperature 1 Temperature 2
37°C, 30 min 70°C, 30 min
ld at 4°CAdd 5 μL of master mix to each multimer tube, for a
total of 15 μL. Place each tube in a thermocycler and
use cycling conditions specified in Table 5 for 1 hour.
4. Multimer amplification (bench time 30 min, total
time 1.3 hours)
To amplify each multimer, combine components
specified in Table 6. Add 49 μL of mix to 1 μL of
multimer template each. Perform multimer PCR
using conditions specified in Table 7.
Day 2
5. Gel electrophoresis and purification of multimers





HoRun all 50 μL sample of each amplified multimer in 1
large well or 2 medium-sized wells on a 2% agarose
gel; include a molecular weight marker. Excise
multimer bands of correct size. To estimate the
correct band size, multiply the number of assembled
monomers by 103 bp and add 20 bp. For example, a
hexamer will run at about 640 bp. When excising the
bands, avoid cross-contamination between multimers
that are intended for assembly of different TALEs.
While bright multimer bands in the range of 20 ng/μL
and above are preferred, lower concentrations (10 ng/
μL range) can be assembled, though with lower
efficiency. Purify the bands using an appropriate gel
purification kit, such as QIAquick Extraction Kit
(Qiagen, Valencia, CA) following manufacturer’s
instructions.
6. Assembly of multimers into vector (bench time 30
min, total time 4.5 hours)
Choose an EZ-TAL™ backbone vector according to
the intended downstream application (see Table 1
for a list of available backbone vectors). The vector
should contain the half-repeat that specifies the lastble 7 Multimer PCR conditions
cle Number Denature Anneal Extend
95°C, 2 min
36 95°C, 20 s 60°C, 20 s 72°C, 30 s
72°C, 3 min
ld at 4°C
Table 8 Components for assembly of multimer into vector




Backbone Vector 1 1
3 Purified Multimers 5* 0
ATP 1 1
T7 Ligase 0.25 0.25
Combo Buffer II 1 1
BSaI enzyme 0.75 0.75
BSA 1 1
DNA-grade H2O 0 5
Total 10 10
*The proportion of each multimer within these 5 μL can be adjusted to
achieve a similar concentration of each multimer in the mix.
Table 10 Components for colony PCR
Component Amount (μL)
dNTP 0.2
Colony-PCR primer mix 0.2
Taq Polymerase (5 U μL-1) 0.1
Taq Polymerase buffer, 10x 2
DNA-grade H2O 16.5
total 19
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DNA target ends with T, use the T-version of the
vector.
Combine the corresponding multimers, vector, and
components of the EZ-TAL™ kit as specified in
Table 8 in a PCR tube for a total of 10 μL. Include a
negative control as shown in Table 8. If
concentration of multimers is below the
recommended range (below 20 ng/μL), reduce
vector concentration accordingly. Place tubes in a
thermocycler and use the cycling conditions
specified in Table 9.
7. Transformation (bench time 30 min, total time 1.5 hours)
Transform competent E. coli with the assembly
product, following manufacturer’s instructions. Plate
transformed E. coli on LB with Carbenicillin (100 μg/L);
alternatively, Ampicillin (100 μg/L) can be used. It is
expected to see tens to hundreds of colonies on plates
transformed with the assembled product, while the
negative control plates should display significantly
fewer or no colonies (Figure 3C).
TALE assembly confirmation
Colony PCR (bench time 30 min, total time 2.2 hours)
Perform a colony PCR of 5–10 colonies per TALE as-
sembly. For template, slightly dip a sterile pipette tip
into a colony, streak an LB plate once to keep track of
the colony, and then dip the pipette tip into a tube with
100 μL sterile H2O. For negative control, swipe over agarTable 9 Thermocycle conditions for assembly of
multimers into vector
Cycle Number Temperature 1 Temperature 2 Temperature 3
1 37°C, 5 min
2-20 20°C, 5 min 37°C, 5 min
21 80°C, 20 min
Hold at 4°Cplate between colonies, and process like a colony dip.
Label colony streaks according to tube numbers, and in-
cubate over night at 37°C.
Set up a colony PCR as specified in Table 10. Add 19
μl of mix to 1 μL of diluted template (colony suspension
or negative control in 100 μL H2O) for a total of 20 μL.
Place tubes in thermocycler, and run using cycling con-
ditions as specified in Table 11.
Agarose gel electrophoresis of colony PCR (bench time 30
min, total time 1.5 hours)
Run all 20 μL of the colony-PCR samples and negative
control on a 1% agarose gel; include a molecular weight
marker. The expected size of the band can be calculated
as number of inserted monomers x 103 bp plus 250 bp.
Sequence confirmation
Inoculate 2 colonies that show a single band of correct
size in LB + Carbenicillin (100 μg/L) or Ampicillin (100
μg/L), and incubate over night for plasmid isolation. For
sequence confirmation, use sequencing primers provided
in the EZ-TAL™ kit, EZ-TAL™ SF1 (forward-1), EZ-
TAL™ SF2 (forward 2), and EZ-TAL™ SR (reverse). For
short TALEs with DNA target sites of 14–15 bp, primer
EZ-TAL™ SF2 can be omitted.
Trouble-shooting advice
Poor multimer amplification
A faint or missing multimer band in combination with
smear in the high molecular-weight range may indicate
failed or impaired exonuclease treatment. Ensure correct
storage conditions of exonuclease enzyme and ATP, and
make sure that all components are added in correct
amounts. Do not skip or shorten exonuclease incubation
time.Table 11 Thermocycle conditions for colony PCR
Cycle Number Denature Anneal Extend
1 94°C, 3 min.
2-31 94°C, 30 s 60°C, 30s 72°C, 2 min
32 72°C, 5 min
Hold at 4°C
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To assess quality and quantity of the gel-purified multi-
mers, run an aliquot on an agarose gel. Multimers of 10
ng/μL and less can still be assembled, but with reduced
efficiency. If concentration of multimers is lower than
recommended (below 20 ng/μL), reduce vector concen-
tration in the assembly step (step 6) accordingly. If ne-
cessary, redo any multimer of low concentration and/or
quality.
Sequence error
About 10-20% of sequenced clones may display a se-
quence error, such as an incorrect repeat or a frame
shift. In this case, we recommend sequencing some add-
itional clones. If this does not reveal an error-free se-
quence, we recommend to redo the multimer that
contains the error, and re-assemble into the vector. Note
that the half-repeat RVD in the EF1-TALE-TF-NG vec-
tor is encoded by AAT GGC instead of AAC GGA, and
that of the TALE-TF-NN vector is encoded by AAT
AAC instead of AACAAC (see Table 1, footnote).
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